- Home
- NNNN vs WLYB Comparison
NNNN vs WLYB Comparison
Compare NNNN & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- WLYB
- Stock Information
- Founded
- NNNN 2021
- WLYB 1807
- Country
- NNNN Germany
- WLYB United States
- Employees
- NNNN N/A
- WLYB N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WLYB Books
- Sector
- NNNN Health Care
- WLYB Consumer Discretionary
- Exchange
- NNNN Nasdaq
- WLYB Nasdaq
- Market Cap
- NNNN 2.2B
- WLYB 2.1B
- IPO Year
- NNNN 2025
- WLYB N/A
- Fundamental
- Price
- NNNN $45.65
- WLYB $39.43
- Analyst Decision
- NNNN
- WLYB
- Analyst Count
- NNNN 0
- WLYB 0
- Target Price
- NNNN N/A
- WLYB N/A
- AVG Volume (30 Days)
- NNNN 88.1K
- WLYB 179.0
- Earning Date
- NNNN 01-01-0001
- WLYB 09-04-2025
- Dividend Yield
- NNNN N/A
- WLYB 3.49%
- EPS Growth
- NNNN N/A
- WLYB N/A
- EPS
- NNNN 0.06
- WLYB 1.53
- Revenue
- NNNN $8,185,146.00
- WLYB $1,677,609,000.00
- Revenue This Year
- NNNN N/A
- WLYB $1.45
- Revenue Next Year
- NNNN N/A
- WLYB $2.70
- P/E Ratio
- NNNN $839.78
- WLYB $25.64
- Revenue Growth
- NNNN 21.95
- WLYB N/A
- 52 Week Low
- NNNN $5.18
- WLYB $37.27
- 52 Week High
- NNNN $55.65
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- WLYB 29.84
- Support Level
- NNNN N/A
- WLYB $39.63
- Resistance Level
- NNNN N/A
- WLYB $42.70
- Average True Range (ATR)
- NNNN 0.00
- WLYB 0.02
- MACD
- NNNN 0.00
- WLYB 0.07
- Stochastic Oscillator
- NNNN 0.00
- WLYB 0.00
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.